RecruitingPHASE2, PHASE3NCT07086755

Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bentley J. Bobrow
Principal Investigator
Paul Potnuru, MD, M.D
The University of Texas Health Science Center, Houston
Intervention
Vadadustat 900mg(drug)
Enrollment
1100 enrolled
Eligibility
18 years · All sexes
Timeline
20252026

Study locations (1)

Collaborators

Akebia Therapeutics Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07086755 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials